Clinical Trials
3 trialsNCT01545141 2023-10-27
Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer
Roswell Park Cancer Institute
Phase 1/2 Terminated
NCT01622933 2017-08-31
Multiple Antigen-Engineered DC Vaccine for Melanoma
University of Pittsburgh
Phase 1 Completed
NCT00234182 2005-12-01
Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC
The University of Hong Kong
Phase 1/2 Completed